Cargando…
Results of NCCTG N0275 (Alliance) – a phase II trial evaluating resection followed by adjuvant radiation therapy for patients with desmoplastic melanoma
To examine, in a prospective fashion, the utilization and efficacy of adjuvant radiation therapy (RT) in patients with resected desmoplastic melanoma (DM). Adult patients with resected, margin‐negative, and nonmetastatic DM were eligible for this single‐arm prospective phase II study. Patients were...
Autores principales: | Rule, William G., Allred, Jacob B., Pockaj, Barbara A., Markovic, Svetomir N., DiCaudo, David J., Erickson, Lori A., Deming, Richard L., Schild, Steven E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971918/ https://www.ncbi.nlm.nih.gov/pubmed/27368067 http://dx.doi.org/10.1002/cam4.783 |
Ejemplares similares
-
Phase II Study of Everolimus in Metastatic Malignant Melanoma (NCCTG‐N0377, Alliance)
por: Vera Aguilera, Jesus, et al.
Publicado: (2018) -
BRAF V600 Mutation Detection in Plasma Cell-Free DNA: NCCTG N0879 (Alliance)
por: Slostad, Jessica A., et al.
Publicado: (2021) -
Testing of candidate single nucleotide variants associated with paclitaxel neuropathy in the trial NCCTG N08C1 (Alliance)
por: Boora, Ganesh K., et al.
Publicado: (2016) -
EGFR expression is associated with decreased benefit from trastuzumab in the NCCTG N9831 (Alliance) trial
por: Cheng, H, et al.
Publicado: (2014) -
Combining Survival and Toxicity Effect Sizes from Clinical Trials: NCCTG 89-20-52 (Alliance)
por: Major-Elechi, Brittny T., et al.
Publicado: (2018)